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Background: Lack of adherence to recommended treatment for obstructive sleep apnea remains an ongoing
public health challenge. Despite evidence that continuous positive airway pressure (CPAP) is effective and improves
overall quality of life, adherence with the use of CPAP in certain racial/ethnic groups, especially blacks, is
suboptimal. Evidence indicates that the incidence and prevalence of obstructive sleep apnea are higher among
blacks, relative to whites, and blacks are less likely to adhere to recommended treatment compared with other
racial/ethnic groups.
Methods: Using a two-arm randomized controlled design, this study will evaluate the effectiveness of a culturally
and linguistically tailored telephone-delivered intervention to promote adherence to physician-recommended sleep
apnea assessment and treatment among blacks with metabolic syndrome, versus an attention-control arm. The
intervention is designed to foster adherence to recommended sleep apnea care using the stages-of-change model.
The intervention will be delivered entirely over the telephone. Participants in the intervention arm will receive 10
phone calls to address challenges and barriers to recommended care. Outcomes will be assessed at baseline, and at
6- and 12-months post-randomization.
Discussion: This tailored behavioral intervention will improve adherence to sleep apnea assessment and treatment
among blacks with metabolic syndrome. We expect to demonstrate that this intervention modality is feasible in
terms of time and cost and can be replicated in populations with similar racial/ethnic backgrounds.
Trial registration: The study is registered at clinicaltrials.gov NCT01946659 (February 2013)
Keywords: Obstructive sleep apnea (OSA), Continuous positive airway pressure (CPAP), Adherence, blacks,
Metabolic syndrome, Telephone-delivered, Health education, Motivational interviewingBackground
Obstructive sleep apnea is a major public health problem in
the United States, affecting an estimated 18 million
Americans [1-3]. It is a serious, potentially life-threatening
condition characterized by repeated cessation of breathing
while sleeping. According to the National Institute of* Correspondence: natasha.williams2@nyumc.org
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diabetes [4]. Others view it as big a public health hazard as
smoking, heart attacks and stroke [3,5]. Using a respiratory
disturbance index (referred to the total number of apneas
(complete cessation of breathing lasting ≥ 10 seconds)), the
Wisconsin Sleep Cohort Study estimated that sleep apnea
affects as much as 15% of men and 5% of women (ages 30
to 60 years) [6]. Prevalence rates are even higher in this age
group when polysomnographic criteria are used, indicating
that 24% of men and 9% of women may have sleep apnea
[7]. Sleep apnea is associated with obesity, hypertensionl Ltd. This is an Open Access article distributed under the terms of the Creative
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(CVD), vehicular accidents, and mortality [8]. It is esti-
mated that sleep apnea is probably responsible for 38,000
cardiovascular deaths yearly, with an associated 42 million
dollars spent on related hospitalizations [9]. Despite these
alarming data, 82% of men and 93% of women with sleep
apnea in the United States remain undiagnosed.
In light of available evidence, sleep apnea assessment
is paramount. Standard of care for sleep apnea assess-
ment typically entails a detailed sleep history, which
is performed by a sleep clinician in a structured setting-
otherwise known as a sleep laboratory. Participants who
are at risk, based on subjective ratings, are routinely re-
ferred for laboratory polysomnography. A nocturnal poly-
somnographic study incorporates assessment of sleep
architecture, airflow and ventilatory effort, arterial blood
saturation, electrocardiogram, body position, and periodic
limb movement [10,11].
The most effective, noninvasive treatment for sleep
apnea requires the use of continuous positive airway
pressure (CPAP) [12]. This treatment requires partici-
pants to wear a sealed mask over the nose, or in certain
cases both the nose and mouth, while sleeping. Partici-
pants receive forced room air via the mask (that has
been fitted by a technician), titrating the pressure in the
oropharyngeal airway, which helps to maintain airway
patency. Use of CPAP as a therapeutic modality for sleep
apnea is often coupled with some form of behavior
modification targeting individual’s weight [13,14].
Being male, overweight, and over the age of 40 years
are risk factors for sleep apnea. Recent data strongly sug-
gest that race/ethnicity should also be considered as an
important risk factor. A home sleep study performed among
community-dwelling adults (aged ≥ 65 years) showed that
blacks (that is, African American, African, or Caribbean
American) were 2.5 times more likely to have an apnea
hypopnea index of 30 or higher compared with whites
[15]. Ethnic disparities in sleep apnea estimates might
even be greater if one considered a respiratory disturbance
index > 10. In effect, in a study comparing 225 black and
622 white volunteers, aged 2 to 86 years, 31% of blacks
versus 10% of whites had sleep apnea [16]. Another
worthy observation in that study is that blacks (≤ 25 years)
may be at greater risk for sleep apnea than their white
counterparts [17]. In our previous work (conducted by the
principal investigator (PI, Dr. Jean-Louis), we demon-
strated that among blacks in Brooklyn, a history of cardio-
vascular disease (CVD) was the most important predictor
of the likelihood of expressing symptoms of sleep apnea,
with a corresponding multivariate-adjusted odds ratio of
11 (95% confidence interval = 3.03 to 40.63) [18]. Despite
alarming evidence that metabolic risk markers (for ex-
ample, obesity, hypertension (HTN), and diabetes mellitus
(DM)) for CVD are more prevalent among blacks [19],the vast majority of suspected cases in minority popula-
tions remain undiagnosed. Under-diagnosis among blacks
is of great concern since the burden of sleep apnea is
worse in that population [16]. Furthermore, while adher-
ence to CPAP therapy remains poor for the general popu-
lation, with only half of participants using CPAP for more
than 4 hours per night, adherence to CPAP treatment
among blacks is abysmally worse. One study conducted
among non-Hispanic Caucasians and non-Hispanic blacks
found that CPAP use among blacks was 2.07 hours less
than among whites [20]. Therefore, the development of
innovative interventions for vulnerable populations, par-
ticularly for blacks, is warranted. Such interventions
may have significant clinical, social and public health
implications.
The primary aim of this on-going randomized trial is
to assess the efficacy of a culturally and linguistically tai-
lored telephone-delivered intervention to increase adher-
ence to physician-recommended assessment and treatment
of sleep apnea. The secondary aims are to: 1) evaluate the
maintenance of intervention effects on adherence at
6 months post-randomization; and 2) assess treatment ef-
fects on indices of the metabolic syndrome (waist circum-
ference, blood pressure (BP), lipid levels and fasting
plasma glucose (FPG) or hemoglobin (HbA1c) for those
who have a DM diagnosis). There are four main hypoth-
eses for this study: 1) participants will show greater adher-
ence to physician-recommended polysomnographic sleep
apnea evaluation during follow-up assessment; 2) partici-
pants will show greater adherence to CPAP treatment
during follow-up assessment; 3) effects of the inter-
vention on adherence rates will be maintained 6 months
after discontinuing active interventions, and treatments
will improve indexes of the metabolic syndrome; and
4) participants’ knowledge about sleep, self-efficacy,
readiness, and trust/rapport with the health educator
(HE) will mediate intervention effects on study outcomes.
The study is registered in clinicaltrials.gov.
Design and methods
This is a randomized controlled trial to examine the effi-
cacy of a culturally and linguistically tailored behavioral
telephone-delivered intervention to increase adherence
to physician-recommended assessment and treatment of
sleep apnea. Participants will be randomized either to a
tailored-telephone intervention (TTI) arm or an attention-
control (AC) arm. Approximately 340 black participants at
risk for sleep apnea will be randomly assigned to one of
the two treatment conditions (170 in each arm). Interven-
tion content for the TTI will be delivered by a trained HE
who has experience working with minority populations.
The HE has a bachelor’s degree and will receive significant
training in sleep medicine, including both basic theories
and laboratory-based recording and treatment procedures.
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lead investigator. Assessments will be conducted at base-
line, and at 6- and 12-months post-randomization. Partici-
pants will receive $10 at baseline and $100 at the 6-month
follow-up.
The institutional review boards (IRBs) at SUNY Down-
state Medical Center (protocol #09-193) and NYU Langone
Medical Center (protocol #13-00182) approved this study
prior to implementation.
Theoretical framework
The intervention is guided by the transtheoretical model
developed by Prochaska et al. (Figure 1) [21]. This behav-
ior change model consists of five stages that the individual
moves through in the process of modifying a problem be-
havior. The first stage begins with pre-contemplation, in
which a person is not considering change and is often un-
aware that they have a problem to be modified; it con-
tinues to the maintenance stage, where the individual has
successfully altered the behavior (for 6 months or more)
and concentrates on maintaining this new way of life.
Between these two stages, the person may contemplate
change, prepare to change, and begin to act to initiate be-
havior change. This model has been applied to a variety of
health behaviors, such as alcohol and substance use,
smoking cessation, condom use, and weight loss [21]. Our
study will examine the relationship between participants’
readiness to use CPAP at the beginning of the intervention
with the success they are likely to achieve in increasing ad-
herence to physician-recommended sleep apnea assess-
ment and CPAP treatment.
Study sites/population
Figure 2 shows a flow chart of participant enrollment. The
study sample will be drawn from a well-characterized
registry of black participants of the Metabolic Syndrome
Outcome Cohort Study (MetSO). A complete description
of the MetSO project has been reported elsewhere [22].
Briefly, MetSO was conducted to increase access to at-risk
minority participants into clinical research and interven-
tion programs. To date, over 1,200 black participants-60%Figure 1 Theoretical framework for the impact of telephone interven
and treatment.being of Caribbean origin - with cardio-metabolic diseases
have been enrolled. Table 1 provides baseline characteris-
tics of the MetSO study population. A subset of 70
participants from the registry was randomly selected to
estimate risk of sleep apnea using the Apnea Risk Evalu-
ation System (ARES™) questionnaire, which includes
questions on sleep patterns, daytime functioning, and
knowledge of sleep apnea [23]. Overall, the rate of sleep
apnea symptoms was: snoring (72%), excessive daytime
sleepiness (65%), and difficulty maintaining sleep (75%).
Of the subsample, 79% reported a history of hypertension,
72% a history of heart problems, and 55% indicated having
a diagnosis of diabetes. Preliminary analysis suggested a
significant number of participants (59%) were at high risk
for sleep apnea. Our pilot work established the infrastruc-
ture and provided estimated sample size to conduct this
randomized controlled trial.
Eligibility criteria
Eligible participants must: 1) self-report their race/ethnicity
as black/African American; 2) be ≥ 18 years old; 3) diagno-
sis of metabolic syndrome; and 4) have a positive screening
for sleep apnea, as measured by the Apnea Risk Evaluation
System (ARES™) questionnaire [23]. Exclusion criteria in-
clude: 1) documented co-existing sleep problems; 2) docu-
mented illness or disability in which death is expected
within two years of enrollment; 3) intent to relocate from
the New York City area within one year following enroll-
ment; 4) non-English speaking; 5) not accessible via tele-
phone; 6) impaired cognitive or functional ability; and
7) another family member participating in the study. All
participants will be asked to provide written informed
consent before enrollment.
Recruitment and screening
We aim to recruit a total of 340 black participants at risk
for sleep apnea. Trained research assistants (RAs) will
contact eligible participants using the MetSO registry,
which includes detailed contact information. If a valid
phone number was not provided, then an invitation will be
mailed to the address on file. The invitation will providetions on adherence to recommended sleep apnea assessment
Figure 2 Depiction of flow of participants in the trial.
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more information about the study. Participants will be
considered ineligible if the invitation is mailed to a wrong
address. During the initial phone call, the RAs will provide
a detailed description of the study. Participants will be
contacted during the day as well as during the evening
hours. Participants who express interest will be screened
for eligibility. The RAs will also collect basic demographic
information that will be used to assess characteristics of
participants who agree to be enrolled versus those who
decline solicitation to enroll in the study protocol. Eligible
participants will receive a packet that includes a briefTable 1 Baseline characteristics of MetSO study
participants
Characteristics All blacks US blacks Caribbean blacks
Age 52.3 ± 12.3 51.17 ± 15.8 53.46 ± 11.6
Female 56.0% 60.8% 52.0%
Male 44.0% 39.2% 48.0%
< High schoola 43.3% 31.2% 53.3%
Hypertension 73.1% 71.6% 76.0%
Diabetes 50.2% 45.6% 54.0%
Dyslipidemia 48.4% 42.4% 53.3%
Obesity 31.6% 34.9% 28.8%
a< High school, education up to less than high school level.questionnaire on sleep problems, medical history, and use
of medications. The packet will also include two educa-
tional brochures about sleep apnea: 'Sleep Apnea: Is Your
Patient at Risk?', produced by the National Heart Lung
and Blood Institute and 'Sleep Apnea', produced by the
American Academy of Sleep Medicine (AASM).
Randomization
Upon completion of the baseline interview, consenting
participants will be randomly assigned to either the TTI
or the AC arms. Randomization will be conducted by
the statistician and will be carried out in pairs using a
table of permutations [24]. This strategy will ensure bal-
ance between the two study arms regarding factors in-
cluding participant characteristics, lifestyle behavior, and
medical comorbidities. Due to the nature of the study,
the HE delivering the intervention will not be blind to
study arms. After completion of the 12-month assess-
ment, all AC participants will be invited to participate in
the TTI. Based on our experience working with this
community, we believe that failure to offer the TTI
could severely jeopardize community relations.
Description of the tailored telephone intervention
The intervention is culturally and linguistically tailored
to address the needs of black participants. We believe
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unique cultural and ethnic norms and values of the tar-
get population in order to have a greater likelihood of
success. Before implementation, we conducted forma-
tive research, including focus groups with the target
population during which the TTI materials were pilot
tested. Study investigators also relied on a commu-
nity advisory board to provide input on the interven-
tion design, including program materials for specific
content areas, such as appropriate messaging and educa-
tional levels.
The intervention will be delivered entirely over the
telephone by a trained HE. It is based on evidence that
telephone-delivered interventions are effective for in-
creasing rates of screening and treatment for various
health problems, including colorectal cancer [25-27] and
depression [28], appointment keeping [29], and adher-
ence to treatment [30,31]. In addition, it is advantageous
because it is cost-effective and participants do not need
to leave their home. Using the transtheoretical model,
each phone contact will be individually tailored to assess
stage of readiness as well as the participant’s level of mo-
tivation. In pre-contemplation, communications will at-
tempt to increase motivation to change. Further along
the continuum, communications will facilitate acting on
motivation and maintaining a behavior. For participants
with low levels of motivation, the goal will be to increase
motivation and commitment; while for those who already
appear motivated, motivation will be enhanced by increas-
ing knowledge, modifying beliefs, and increasing the value
placed on sleep assessment.
Phase I - sleep apnea assessment
Within 2 weeks following randomization, the HE will con-
tact participants assigned to the TTI arm by telephone
using a detailed script to guide each phone contact. The
goals of the first telephone contact will be to obtain a de-
tailed assessment of the participant’s knowledge, attitudes,
and behaviors related to sleep and to improve understand-
ing of sleep apnea. The HE will emphasize the need for
participants to undergo a sleep apnea assessment at a local
sleep center. The HE will also provide participant naviga-
tion and identify logistical barriers to receiving the sleep
assessment, such as transportation, and intervene as ne-
cessary. During this phone contact the HE will assess par-
ticipants’ stage of readiness to change and will counsel the
participant accordingly. Once a verbal commitment to
schedule a sleep assessment is established, the HE will rec-
ord the date and time of the appointment and will follow
up with participants the day after to determine if the ap-
pointment was kept. If participants do not keep the ap-
pointment the HE will identify obstacles and will work
with participants to achieve the intended goal. In cases
where participants keep the appointment, the HE willinquire about the outcome of the assessment, including
whether or not there was a diagnosis of sleep apnea.
For participants with a confirmed diagnosis of sleep
apnea, the emphasis will be on treatment for sleep apnea
(see 'Phase II - adherence to CPAP treatment and mainten-
ance' below). The HE will be instructed to make up to 10
phone calls, each lasting up to 25 minutes with an average
of 10 minutes per call. The HE will keep implementation
logs. These will contain date and time of attempted and
completed calls, length of call, participant’s level of com-
mitment to receive an assessment and follow-up care, par-
ticipant’s self-report of obtaining the assessment and
follow-up, type of barriers encountered and ways to over-
come them, and time spent discussing various topics (for
example, sleep apnea, other health-related topics, personal
issues).Phase II - adherence to CPAP treatment and maintenance
During phase II, emphasis will be on CPAP adherence
where the HE will work with participants to facilitate
acceptance and adherence to prescribed CPAP treatment.
Similar to phase I, a standardized intervention script will
be used. The HE will work with the participants to identify
barriers and focus on strategies for maintaining treatment
and behavior change. In addition to receiving continued
support and education, participants will be instructed
about the importance of receiving the appropriate follow-
up care at the sleep center. During these phone contacts
the HE will emphasize that sleep apnea is a chronic condi-
tion that requires ongoing self-management.Follow-up procedures
Participants will be instructed that appropriate manage-
ment of their condition may require attending approxi-
mately three clinic visits at the sleep center; the number
of visits will vary based on the participants’ diagnosis.
During the first visit to the sleep center, participants will
have a consultation with the sleep specialist, and
complete questionnaires. The sleep specialist will con-
duct an overview of the participant’s sleep history, and
medical history including BP, blood glucose and other
health behaviors (for example, regularity of physical ex-
aminations, cholesterol screening, smoking and drinking
habits, and exercise habits) will be assessed. This initial
consultation will also provide participants with another
opportunity to ask any questions pertaining to the study
procedures and to help participants feel comfortable
with the testing environment. Upon diagnosis of sleep
apnea, participants will complete a follow-up visit that
will include an overnight CPAP titration study. Partici-
pants will receive additional information on how to use
the device and participants will be reminded that the HE
will be available to answer any further questions.
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The standard of care for adults with sleep apnea includes
a referral for a comprehensive assessment of sleep apnea
and provision of standard print communications about
sleep apnea produced by the National Institutes of Health
and the AASM. Participants in the control arm will re-
ceive up to 10 phone calls from a RA to provide informa-
tion about sleep apnea and information about available
resources. During these phone calls, no tailored behavioral
change strategies will be used. The periodic phone calls
are consistent with current practice of many medical facil-
ities that have adopted the policy of making multiple
phone calls to remind participants of scheduled doctor’s
appointments. In addition, instituting this procedure en-
sures that differences in adherence rates are attributed
solely to the delivery of the intervention.
Exit interviews
Finally, all participants will be debriefed. Participants will
complete the same baseline questionnaires and additional
questionnaires designed to understand why participants
adhered to the intervention and how the intervention
might be refined to be more effective.
Data safety and monitoring
In compliance with the National Institutes of Health reg-
ulations, an internal data and safety monitoring commit-
tee has been developed. The purpose of the committee
is to ensure the safety of participants and the validity
and integrity of the data. The committee will meet once
per year to monitor the overall conduct of the study. In
addition, all participants will be subject to a chart audit
and participants will undergo physical exams before and
after the intervention. During both visits, participants
will be asked to bring bottles of any medications they
are currently taking, including statins, antihypertensive,
antihyperglycemic, and sleep medications (prescribed
and/or over the counter). Trained RAs will note each
medication, its name, drug class, and the doses at base-
line. During follow-up visits, the RAs will note if there
are any changes to any of the medications noted at the
previous visit and if a new medication has been added.
Participants will be monitored during the course of data
acquisition and any health concerns that may arise will
be addressed, particularly among participants with no
identifiable primary-care physicians, in which referrals
will be made to primary-care clinics.
Treatment fidelity
A comprehensive plan for training the HE was essential to
the development of the intervention. The training curricu-
lum includes an overview of sleep medicine, the recom-
mended AASM guidelines, stages of readiness, and cultural
sensitivity. Prior to recruitment, the HE received 30 hoursof training in sleep medicine. The HE will be continuously
monitored throughout the study period to ensure adher-
ence to study protocol and ascertain knowledge and appli-
cation of the AASM obstructive sleep apnea assessment
and treatment guidelines. At the beginning of the study,
the HE was required to attend workshops on cultural
sensitivity. Moreover, the HE was selected based on her
experience working with minority populations. The HE
received additional training in individual tailoring of
intervention approaches based on participants’ stage
of readiness. During the training, the HE was observed
implementing the intervention protocol and sample activ-
ities. This allowed the HEs to receive feedback from the PI
and team members who suggested ways to overcome chal-
lenges and barriers. Finally, the HE will meet with the
study PI on a bi-monthly basis for a progress report, dis-
cussing challenges encountered during the TTI delivery.
Qualitative evaluation
Another unique component of this study is that we inte-
grated qualitative research with the randomized con-
trolled trial design. At the completion of the trial we will
conduct focus groups to assess participants’ overall
impressions of the intervention. More specifically, we will
conduct four focus groups (two with each arm) with a
sample of eight to ten participants in each group 6 months
after completion of the study to ascertain the follow-
ing: what did participants like and not like about the
intervention? How could it have been done better?
Which components were most responsible for promoting
changes? Why did some seek an assessment of sleep
apnea (and used CPAP) while others did not? Which
intervention components were most and least accept-
able? Were there any critical incidents that prompted re-
spondents to get a sleep apnea assessment? How could
the intervention be changed to make it more effective? A
semi-structured interview guide will be developed based




Sociodemographic variables will include age, type of
health insurance, marital status, education, place of birth
(for example, US versus Caribbean), years in current resi-
dence and locality, number of children living in house-
hold, number of adults living in household, self-described
ethnicity, and annual household income.
Apnea-risk evaluation system questionnaire
This tool includes questions on sleep patterns, daytime
functioning, knowledge of sleep apnea, and diseases
associated with sleep apnea (that is, HTN, DM, heart
disease) [23].
Table 2 Schedule to acquire study data










Epworth sleepiness scale X X
CES-D X X
Apnea knowledge test X X




Self-efficacy scale X X
Change assessment scale X
Functional outcomes in sleep
questionnaire
X X
Process variables X X
Post hoc evaluation variables X
Sleep variables (chart audit) X
aFollow-up outcome ascertainment is performed by the Data Manager at
6 months post-enrollment and at 6 months post-telephone intervention (TTI).
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This questionnaire uses a Likert-type scale in which the re-
spondent indicates the most appropriate number ranging
from 0 =would never doze or sleep to 3 = high chance of
dozing or sleeping based on a given situation. A score of
10 or more is considered excessive sleepiness [32].
Apnea knowledge test and apnea beliefs scale
These two questionnaires assess participants’ under-
standing and beliefs of obstructive sleep apnea and
CPAP treatment. The AKT includes 13 questions with a
yes/no response choice and 2 open-ended questions; the
ABS includes 24 items on a five-point Likert scale ran-
ging from 'strongly agree' to 'strongly disagree'. A higher
score on the AKT indicates better knowledge and under-
standing of the illness and treatment and a higher score
on the ABS indicates greater likelihood of adherence to
treatment [33].
Change assessment scale
This is a 32-item instrument that assesses a person’s readi-
ness to change. Participants evaluate the extent to which
they strongly agree or strongly disagree with various state-
ments such as, 'I’ve been thinking that I might want to
change something about myself' and 'I have problems and
I really think I should work on them' [34].
Medical history
Medical history includes family history of sleep disor-
ders, obesity, DM, HTN, dyslipidemia, and CVD; history of
other preventive behaviors (for example, prostate exams),
and other health behaviors (for example, regularity of
physical examinations, cholesterol screening, smoking and
drinking habits, and exercise habits).
Adherence to CPAP
We will assess CPAP adherence using subjective and ob-
jective measures. A self-report scale will be used to track
CPAP adherence at the end of the 6-month period. CPAP
adherence is defined as the mean number of hours per
day and days per week participants report using CPAP
[35,36] (adherence: > 4 hours a night for 70% of the nights
or no report of symptomatic complaints). Throughout the
study, CPAP adherence data will be electronically moni-
tored on a daily basis. Data will be downloaded directly
from CPAP devices [37].
A complete list of measures and the data collection
schedule is provided in Table 2.
Cardio-metabolic measures are as follows. (1) Weight
will be measured without shoes and using a validated
digital scale. (2) Waist circumference will be measured
by 1) locating the upper hip bone and the top of the
right iliac crest, 2) placing the measuring tape horizon-
tally around the abdomen at the level of the iliac crest(tape is snug without causing compression), and 3) meas-
uring at the end of a normal expiration. (3) BP measure-
ments will be taken following American Heart Association
guidelines [38]. Using a BPTru automated BP monitor, five
readings will be obtained while participants are seated
comfortably for five minutes prior to measurement [39];
the average BP will be used as the BP index for each visit.
(4) Following the National Cholesterol Education Program
standard guidelines for total cholesterol measurement, we
will use the Cholestech LDX Analyzer; whole blood from
fingersticks will be used for the quantitative determination
of HDL-C and FPG utilizing established formulation [40].
All measurements will be collected by trained clinical re-
search staff.
Outcomes
The primary outcome will be adherence to physician-
recommended assessment and treatment for sleep apnea.
The secondary outcomes will include 1) maintenance of
recommended treatment at 6 months and at 12 months;
2) waist circumference; 3) lipid levels; 4) BP; and 5) FPG
or HbA1c for those who have a DM diagnosis. Outcomes
assessment will be conducted at baseline, and at 6- and
12-months post-randomization.
Chart audit
Upon completion of a sleep assessment, a participant’s
chart (intervention or attention control) will be subjected
to a random audit. Audits for confirming self-report will
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be blinded to randomization status. Verification of a sleep
assessment entails documentation of an appropriate sleep
history and a polysomnographic study.Statistical analysis
To describe the characteristics of the study population,
we will use measures of central tendencies and dispersion
for continuous data; frequency distributions will be used for
categorical data. Chi-square tests will be used to compare
categorical data, and ANOVA will be used for continuous
data. Relationships between mediators of adherence to
recommended sleep apnea assessment and CPAP treat-
ment will be examined using binary multivariate logistic
regression analysis. The two main dependent measures
will be: adherence to physician-recommended sleep as-
sessment (yes versus no) and adherence to CPAP treat-
ment (yes versus no). Candidate mediators will include
sleep apnea knowledge, self-efficacy, readiness, and trust/
rapport with the HE. Effects of sociodemographic and clin-
ical factors will be adjusted in those analyses. Repeated-
measures MANCOVA will be used to examine differences
between baseline and follow-up measures (for example,
waist circumference (WC), BP, HDL-C, FBG/HbA1c);
age, sex, and sleepiness will be entered as covariates.
MANCOVA is a robust technique that incorporates
routines to account for heterogeneous variances, serial
correlations, and variance inflation [41].Hypothesis 1
TTI will lead to higher rates of sleep apnea assessment
at 6 months. A comprehensive assessment of sleep apnea
will be defined by documentation of an appropriate med-
ical and sleep history by a sleep clinician and a nocturnal
polysomnographic study.Analysis for hypothesis 1
Analysis will be performed on an intention-to-treat
basis. All participants in the treatment arm will be as-
sumed to have received the full dose of the telephone
intervention and all participants in the attention-control
arm will be assumed to have received no tailored inter-
vention. Prior to testing for intervention effects, we will
verify the comparability of the treatment and control
arms with respect to all available demographic and per-
sonal data. T-tests and chi-square tests will be used for
continuous and categorical variables, respectively. Thus,
receipt of sleep apnea assessments within the 6-month
period will be a binary outcome, yes or no. We will use
logistic regression to estimate the odds associated with
receipt of sleep apnea assessment contrasting the two
study arms.Hypothesis 2
TTI will lead to higher adherence rates to recommended
follow-up care (that is, CPAP use (> 4 hours a night for
70% of the nights)) post-diagnosis of sleep apnea.
Analysis for hypothesis 2
The analysis plan is similar to that for hypothesis 1. The
focus will be on adherence to recommended CPAP treat-
ment. We will use logistic regression to estimate the
likelihood of adhering to prescribed CPAP treatment
after a diagnosis of sleep apnea was made.
Hypothesis 3
Effects of the intervention in maintaining adherence will
be sustained 6 months after active interventions and in-
terventions will improve clinical outcome measures
(WC, BP, HDL-C, and FPG/HbA1c).
Analysis for hypothesis 3
We will test the hypothesis that participants in the inter-
vention arm will sustain gains from the initial interac-
tions with the HE, leading to long-term adherence to
recommended treatment and follow-up care. It is rou-
tinely recommended that participants with sleep apnea re-
turn for a follow-up visit after initiating treatments,
during which adherence to treatment plan and improve-
ment in sleep parameters is assessed. In our protocol, clin-
ical outcomes (WC, BP, HDL-C, and FPG/HbA1c) will be
ascertained post treatment. The analysis plan to test ad-
herence at 6 months post-randomization is similar as for
hypotheses 1 and 2; participants returning for a follow-up
visit will be grouped as long-term adherents versus non-
adherents. Chi-square tests and logistic regression ana-
lyses will be used. Repeated-measures MANCOVA will be
employed to examine differences between baseline and
post-intervention measures (WC, BP, HDL-C, and FPB/
HbA1c). Post hoc comparisons between groups will be
performed with Bonferroni corrections, where univari-
ate results are significant. As required by assumptions
governing the use of ANOVA, and since we expect the
dependent variables to be modestly correlated, we will first
examine their collinearity. Next, normality of the distribu-
tion of each measure will be examined and transforma-
tions will be performed for non-gaussian distributions. In
exploratory analyses, we will determine whether mixed ef-
fect modeling would support ANOVA results.
Power and sample size calculations
Data obtained from a random sample of black partici-
pants recruited from the MetSO Cohort Study has pro-
vided a current estimate of the rate of comprehensive
assessment of sleep apnea to be expected in the pro-
posed study. Analysis of the data suggested that 47% of
participants referred for sleep assessment would adhere
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whereas 35% of those in a control group agreed to undergo
a sleep assessment. Thus, this represents the likely rate of
adherence expected in our AC group. We propose to
achieve an adherence rate of 47% among participants ex-
posed to the TTI.
With an expected 12% increase in the adherence rate
associated with the TTI, a standard error of 0.10%, and a
sample size of 340, the study will be adequately powered
(90%) to detect significant increase in the outcome mea-
sures using chi-square tests. The primary study outcome
in this project is documented receipt of a sleep apnea as-
sessment. A two-tailed test, with alpha = 0.05, comparing
adherence rates of 35% with 47% requires 170 partici-
pants per group [42]. The precision estimated in that
analysis is the approximate expected precision of study
data. Specifically, a difference of 12% would be observed
at chi-square = 21.03 with a 95.0% confidence interval of
3% to 20%. With the proposed sample size, the study will
have 85% power to achieve a one-standard deviation in-
crease in the odds ratio of adherence attributable to pro-
posed mediators: sleep apnea knowledge, self-efficacy,
readiness, and trust/rapport with the HE (expressed as
continuous variables).
Qualitative analysis
For the qualitative analysis, focus groups will be recorded
and transcribed verbatim. Field notes from the HE will also
be collected and reviewed. Transcripts will be reviewed
line-by-line and assigned codes or labels. Similar codes will
be grouped into higher order concepts and then categories.
Similar categories will be clustered to form overarching
themes. These themes will be the major headings describ-
ing barriers to adherence with appointment keeping and
using CPAP. A detailed codebook of the analytic process
will be maintained. Two independently trained RAs will re-
view the transcripts and serve as corroborators. Data ana-
lysis will be aided by (Nvivo) software [43,44].
Discussion
The intervention is designed to be practical so that, if ef-
ficacy is demonstrated, it can be widely disseminated.
The intervention relies on one-to-one personal contact,
a proven method to effect behavioral change, particularly
in populations with low levels of literacy and trust. We
expect to demonstrate that TTI is feasible in terms of
time and cost.
The significance of the intervention lies in its ability to
address a public health need in a high-risk population
and minimize health disparities, to evaluate an interven-
tion that can reduce sleep apnea-related morbidity in
the community, and to improve understanding about
how such interventions can be effectively implemented
in other settings.Trial status
The MetSO trial began in January 2010. To date a total
of 311 participants have been randomized to receive ei-
ther TTI or usual care.
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